News by Subject Policy & Ethics

Communication breakdowns between care facilities can pave the way for outbreaks of infection, according to research on the spread of an extensively drug-resistant bacterium.

Patients who have the wrong idea about the goals of clinical research may become better informed through a non-burdensome scientific reframing intervention, according to a study published Sept. 20, 2017, in the open-access journal PLOS ONE by Paul Christopher from Brown University, United States, and colleagues.

Everybody wants a healthy life for their baby. Black babies are more likely to be born prematurely, which puts them at risk for death and developmental problems. In fact, a third of all infant deaths are preterm-related. The critical period in preterm babies' lives is when they are just born and are in the neonatal intensive care unit (NICU). The care they receive is vital to a healthy future.

In 'Ethics and the Legalization of Physician-Assisted Suicide,' an updated paper published in Annals of Internal Medicine, the American College of Physicians reaffirmed its opposition to the legalization of physician-assisted suicide and affirmed a professional responsibility to improve the care of dying patients.

The American College of Physicians is reaffirming its opposition to the legalization of physician-assisted suicide and affirming a professional responsibility to improve the care of dying patients.

The pending termination of DACA may reverse these mental health benefits for the 800,000 DACA beneficiaries, and trigger a public health crisis, according to an essay in the New England Journal of Medicine, co-authored by Atheendar. S. Venkataramani, MD, PhD, an assistant professor of medical ethics and health policy at Perelman School of Medicine at the University of Pennsylvania.

In at least 18 states around the United States, academic health science centers are partnering with cooperative extension systems to better address population health. This research appears in the September/October 2017 Annals of Family Medicine.

This research is published in the September/October 2017 Annals of Family Medicine.

Medicare spent more than $1 billion over a five-year period on a high-priced drug that has not been proven more effective for a collection of inflammatory conditions than much less expensive corticosteroids.